MOLTENI, ELISABETTA
 Distribuzione geografica
Continente #
NA - Nord America 168
EU - Europa 118
AS - Asia 60
AF - Africa 1
OC - Oceania 1
SA - Sud America 1
Totale 349
Nazione #
US - Stati Uniti d'America 168
CN - Cina 59
IE - Irlanda 53
IT - Italia 20
DE - Germania 16
FI - Finlandia 16
UA - Ucraina 5
BE - Belgio 3
RU - Federazione Russa 2
SE - Svezia 2
AT - Austria 1
AU - Australia 1
CL - Cile 1
JP - Giappone 1
MU - Mauritius 1
Totale 349
Città #
Dublin 53
Chandler 43
Ashburn 16
New York 12
Beijing 10
Helsinki 10
Nanjing 10
Pavia 10
Jacksonville 9
Lawrence 7
Medford 7
Nanchang 7
Princeton 7
Wilmington 7
Jiaxing 6
Shenyang 6
Ann Arbor 4
Shanghai 4
Brussels 3
Hangzhou 3
Hebei 3
Naples 2
Sesto San Giovanni 2
Tianjin 2
Boardman 1
Changsha 1
Dearborn 1
Fairfield 1
Fuzhou 1
Huzhou 1
Kunming 1
Mainz 1
Mariano Comense 1
Melbourne 1
Ningbo 1
Noale 1
Norwalk 1
Seattle 1
Woodbridge 1
Wuhan 1
Zhengzhou 1
Totale 260
Nome #
Benzothiazinones Are Suicide Inhibitors of Mycobacterial Decaprenylphosphoryl-β-d-ribofuranose 2'-Oxidase DprE1. 61
Structural Basis for Benzothiazinone-Mediated Killing of Mycobacterium tuberculosis. 59
Clinical significance of somatic mutation in unexplained blood cytopenia 59
Integrating clinical features and genetic lesions in the risk assessment of patients with chronic myelomonocytic leukemia 55
Co-mutation pattern, clonal hierarchy, and clone size concur to determine disease phenotype of SRSF2 P95-mutated neoplasms 48
Disclosing the impact of carcinogenic SF3b mutations on pre-mRNA recognition via all-atom simulations 38
Incidence and Prognosis of Clonal Hematopoiesis in patients with Chronic Idiopathic Neutropenia 30
Relationship between clone metrics and clinical outcome in clonal cytopenia 20
Totale 370
Categoria #
all - tutte 1.368
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.368


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20192 0 0 0 0 0 0 0 0 0 0 0 2
2019/202058 16 22 0 1 0 1 0 2 3 2 11 0
2020/202124 5 1 0 1 0 1 1 4 4 1 1 5
2021/202235 2 2 1 1 0 3 0 1 4 0 4 17
2022/2023150 12 13 2 8 11 7 0 10 74 0 12 1
2023/202471 10 17 4 7 6 18 0 7 0 2 0 0
Totale 370